The largest database of trusted experimental protocols

2 protocols using anti cd34 coated beads

1

Differentiation of iMACs from hiPSC-derived HSCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
HSCs were generated from hiPSCs using STEMdiff Hematopoietic Kit (StemCell Technologies), according to the manufacturer’s instructions. All cell culture in this method was performed under normoxic conditions. Cells harvested on day 12 were differentiated into iMACs based on either of following protocols: HSCs underwent magnetic sorting (MACS) using anti-CD34-coated beads (Miltenyi Biotec) and cultured for 7 days in RPMI (Corning) supplemented with 10% FBS, 1% penicillin/streptomycin (Thermo Fisher Scientific), and 100 ng/ml M-CSF (Peprotech). Harvested cells underwent further differentiation in the same media described above and were followed by MACS sorting using anti-CD45-coated beads (Miltenyi Biotec) on day 19. As the quality of HSCs harvested on day 12 was the most critical for generating well matured iMACs on day 19, we defined a differentiation as successful when both the harvested cell number on day 12 was more than 500,000 per well in a 12-well plate, and the cell viability was more than 70%. Once matured, 2D-iMACs were maintained under the same condition as described in 3D culture method or polarized into M1-like phenotype by culturing for 24 hours with the combination of 20 ng/ml IFN-γ (Peprotech) and 10 ng/ml LPS (MilliporeSigma).
+ Open protocol
+ Expand
2

Isolation and Culture of CD34+ HSPCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
CD34+ hematopoietic stem/progenitor cells (HSPCs) were sorted from the cord blood of healthy donors from the First Affiliated Hospital of Anhui Medical University using Ficoll-Paque PLUS (GE Healthcare Life Sciences, Stockholm, Sweden) and anti-CD34-coated magnetic beads (Miltenyi Biotec, Bergishgradbach, Germany). Mononuclear cells were isolated from fresh cord blood as previously described. A single-cell suspension was incubated with anti-CD34-coated beads and selected on MACS (Miltenyi Biotec, Bergishgradbach, Germany). The purity of CD34+ cells was analyzed by flow cytometry (CytoFLEX, Beckman Coulter, Miami, FL, USA) following incubation with anti-CD34 antibodies (BioLegend, San Diego, CA, USA). Primary CD34+ HSPCs were cultured in StemSpan SFEM medium (StemCell Technologies, Vancouver, BC, Canada) supplemented with 2 mmol/L L-glutamine (Sigma-Aldrich, St. Louis, MO, USA), 1% Lipid Mixture 1 (L0288, Sigma-Aldrich, St. Louis, MO, USA), 100 ng/mL SCF (Human origin, PeproTech, Rocky Hill, CT, USA), 2 ng/mL IL-3 (Human origin, PeproTech, Rocky Hill, CT, USA), and 1% penicillin-streptomycin.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!